Results of a thematic analysis to explore the experiences of patients with schizophrenia taking antipsychotic medication

Clinical Therapeutics

Volumn 31, Issue SUPPL. 1, 2009, Pages 1488-1496

  Rofail, Diana ^a   Heelis, Rebecca ^b   Gournay, Kevin ^c  

^a Mapi Values   (United Kingdom)

^b BIRMINGHAM AND SOLIHULL MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

antipsychotic agents; patient care management; qualitative research; schizophrenia; subjective experiences

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; ENVIRONMENTAL FACTOR; FAMILY RELATION; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; OPEN ENDED QUESTIONNAIRE; PATIENT ATTITUDE; RELIGION; SCHIZOPHRENIA; SYMPTOM; THEMATIC ANALYSIS;

ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; QUALITY OF LIFE; SCHIZOPHRENIA;

EID: 68849123497     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2009.07.001     Document Type: Article

References (51)

1. Department of Health. The National Health Service Mental Health Framework (1999), Department of Health, London, UK
2. Department of Health. The National Service Health Plan: A Plan for Investment, A Plan for Reform (2000), Department of Health, London, UK Report no. CM 4818-I
3. Schizophrenia (update): Core interventions in the treatment and management of schizophrenia in primary and secondary care (update). http://www.nice.org.uk/guidance/index.jsp?action=byID&o=11786 Accessed April 11, 2009
4. Guidelines: Patient Involvement (2005), International Alliance of Patients' Organizations, London, UK
5. Policy Statement: Patient Involvement (2005), International Alliance of Patients' Organizations, London, UK
6. Awad A.G., Hogan T.P., Voruganti L., and Heslegrave R.J. Patients' subjective experiences on antipsychotic medications: Implications for outcome and quality of life. Int Clin Psychopharmacol. 10 (1995) 123-132
7. Elkes J., and Elkes C. Effect of chlorpromazine on the behavior of chronically overactive psychotic patients. Br Med J. 2 (1954) 560-565
8. Buchanan A. A two-year prospective study of treatment compliance in patients with schizophrenia. Psychol Med. 22 (1992) 787-797
9. Gerlach J., and Peacock L. Intolerance to neuroleptic drugs: The art of avoiding extrapyramidal syndromes. Eur Psychiatry. 10 Suppl 1 (1995) S27-S31
10. American Psychiatric Association. Practice guideline for the treatment of patients with schizophrenia. Am J Psychiatry. 154 (1997) 1-63
11. Bebbington P.E. The content and context of compliance. Int Clin Psychopharmacol. 9 Suppl 5 (1995) 41-50
12. Cramer J.A., and Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv. 49 (1998) 196-201
13. Adams J., and Scott J. Predicting medication adherence in severe mental disorders. Acta Psychiatr Scand. 101 (2000) 119-124
14. DeQuardo J.R., and Tandon R. Do atypical antipsychotic medications favorably alter the long-term course of schizophrenia?. J Psychiatr Res. 32 (1998) 229-242
15. Gray R., Wykes T., and Gournay K. From compliance to concordance: A review of the literature on interventions to enhance compliance with antipsychotic medication. J Psychiatr Ment Health Nurs. 9 (2002) 277-284
16. Naber D., and Kasper S. The importance of treatment acceptability to patients. Int J Psychiatr Clin Pract. 4 Suppl 1 (2000) S25-S34
17. Masand P.S., and Narasimhan M. Improving adherence to antipsychotic pharmacotherapy. Curr Clin Pharmacol. 1 (2006) 47-56
18. Raynor D.K., Blenkinsopp A., Knapp P., et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess. 11 (2007) iii
19. Raynor D.K., Blenkinsopp A., Knapp P., et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess. 11 (2007) 1-160
20. Dowell J., and Hudson H. A qualitative study of medication-taking behaviour in primary care. Fam Pract. 14 (1997) 369-375
21. Morris L.S., and Schulz R.M. Medication compliance: The patient's perspective. Clin Ther. 15 (1993) 593-606
22. Pound P., Britten N., Morgan M., et al. Resisting medicines: A synthesis of qualitative studies of medicine taking. Soc Sci Med. 61 (2005) 133-155
23. Katchnig H., Freeman H., and Sartorius N. Quality of Life in Mental Disorders (1997), John Wiley & Sons, Chichester, UK
24. Fleming K., Goldberg T.E., Gold J.M., and Weinberger D.R. Verbal working memory dysfunction in schizophrenia: Use of a Brown-Peterson paradigm. Psychiatr Res. 56 (1995) 156-161
25. Atkinson M., Zibin S., and Chuang H. Characterizing quality of life among patients with chronic mental illness: A critical examination of the self-report methodology. Am J Psychiatry. 154 (1997) 99-105
26. Waring E.M., Neufeld R.M., and Schaefer B. The thought disorder questionnaire. Can J Psychiatry. 48 (2003) 45-51
27. Day J.C., Bentall R.P., Roberts C., et al. Attitudes toward antipsychotic medication: The impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry. 62 (2005) 717-724
28. Gray R., Rofail D., Allen J., and Newey T. A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication. J Adv Nurs. 52 (2005) 31-37
29. Green J., and Britten N. Qualitative research and evidence based medicine. BMJ. 316 (1998) 1230-1232
30. Gee L., Pearce E., and Jackson M. Quality of life in schizophrenia: A grounded theory approach. Health Qual Life Outcomes 1 (2003) 31
31. Carrick R., Mitchell A., Powell R.A., and Lloyd K. The quest for well-being: A qualitative study of the experience of taking antipsychotic medication. Psychol Psychother. 77 (2004) 19-33
32. Pyne J.M., Sweeney J., Kane J.S., et al. Agreement between patients with schizophrenia and providers on factors of antipsychotic medication adherence. Psychiatr Serv. 57 (2006) 1170-1178
33. Jenkins J.H., Strauss M.E., Carpenter E.A., et al. Subjective experience of recovery from schizophrenia-related disorders and atypical antipsychotics. Int J Soc Psychiatry. 51 (2005) 211-227
34. Rofail D., Gray R., and Gournay K. The development and internal consistency of the Satisfaction with Antipsychotic Medication (SWAM) scale. Psychol Med. 35 (2005) 1063-1072
35. Britten N. Qualitative interviews in medical research. BMJ. 311 (1995) 251-253
36. Patton M.Q. How to Use Qualitative Methods in Evaluation (1987), Sage Publications, London, UK
37. Braun V., and Clarke V. Using thematic analysis in psychology. Qual Res Psychology. 3 (2006) 77-101
38. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition (1994), American Psychiatric Association, Washington, DC
39. King D.J., Burke M., and Lucas R.A. Antipsychotic drug-induced dysphoria. Br J Psychiatry. 167 (1995) 480-482
40. Buis W. Patients' opinions concerning side effects of depot neuroleptics. Am J Psychiatry. 149 (1992) 844-845
41. Lieberman J.A., Stroup T.S., McEvoy J.P., et al., Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 353 (2005) 1209-1223
42. Fenton W.S., Blyler C.B., and Heinssen R.K. Determinants of medication compliance in schizophrenia: Empirical and clinical findings. Schizophr Bull. 23 (1997) 637-651
43. Huffman M.H. Compliance, health outcomes, and partnering in PPS: Acknowledging the patient's agenda. Home Healthc Nurse. 23 (2005) 23-28
44. Frangou S., and Murray R.M. Schizophrenia (1997), Martin Dunitz, London, UK
45. Estroff S.E. Self, identity, and subjective experiences of schizophrenia: In search of the subject. Schizophr Bull. 15 (1989) 189-196
46. Mulholland C., and Cooper S. The symptoms of depression in schizophrenia and its management. Adv Psychiatric Treat. 6 (2000) 169-177
47. Karatzias T., Gumley A., Power K., and O'Grady M. Illness appraisals and self-esteem as correlates of anxiety and affective comorbid disorders in schizophrenia. Compr Psychiatry. 48 (2007) 371-375
48. Glaser B.G., and Strauss A. The Discovery of Grounded Theory: Strategies in Qualitative Research (1967), Aldine, Chicago, Ill
49. Strauss A.L. Qualitative Analysis for Social Scientists (1987), Cambridge University Press, New York, NY
50. Glaser B.G. Theoretical Sensitivity: Advances in the Methodology of Grounded Theory (1978), Sociology Press, Mill Valley, Calif
51. Strauss A., and Corbin J. Basics of Qualitative Research: Grounded Theory Procedures and Techniques (1990), Sage Publications, Newbury Park, Calif